Brief: Beroni Group Says Study Of Its SARS-CoV-2 Antigen Test Kit Showed Overall Sensitivity Of 95%
31/08/2021 13:47
Aug 31 (Reuters) - Beroni Group Ltd BTG.NH :
* BERONI GROUP - LATEST CLINICAL STUDY OF ITS SARS-COV-2
ANTIGEN
TEST KIT DEMONSTRATED AN OVERALL SENSITIVITY OF 95% AND
SPECIFICITY OF 100%.
Source text for Eikon: ID:nGNX768ZjS
Further company coverage: BTG.NH
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beroni
See all newsBrief: Beroni Group’s Enhanced Covid-19 Antigen Rapid Test Kit Received CE Certification
Brief: Beroni Group Ltd Files For A U.S. IPO
Received Part Payment Of A $1.07 Mln Order For SARS-COV-2 Antigen Test Kit From A Japanese Pharma Co
Brief: Beroni Group Gets Approval For R&D Rebate From Australian Government
Brief: Beroni Group Says Study Of Its SARS-CoV-2 Antigen Test Kit Showed Overall Sensitivity Of 95%